Keith W. Marshall

Insider Reports History

Location
San Diego, CA
Signature
/s/ Keith W. Marshall
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Keith W. Marshall:

Company Role Class Num Shares Value Price $ Report Date Ownership
Prometheus Biosciences, Inc. Chief Financial Officer Common Stock 0 $108.42 16 Jun 2023 Direct
Prometheus Biosciences, Inc. Chief Financial Officer Stock Option (right to buy) 0 16 Jun 2023 Direct

Insider Reports Filed by Keith W. Marshall

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000089924323015754-marshall-keith-w-2023-06-16 Prometheus Biosciences, Inc. 16 Jun 2023 8 $0 4 Chief Financial Officer 16 Jun 2023, 16:00
/report/000120919123034038-marshall-keith-w-2023-06-02 Prometheus Biosciences, Inc. 02 Jun 2023 2 +$242,302 4 Chief Financial Officer 02 Jun 2023, 19:03
/report/000120919123023869-marshall-keith-w-2023-04-05 Prometheus Biosciences, Inc. 05 Apr 2023 3 -$1,047,200 4 Chief Financial Officer 07 Apr 2023, 21:02
/report/000120919123017435-marshall-keith-w-2023-03-06 Prometheus Biosciences, Inc. 06 Mar 2023 3 -$1,184,300 4 Chief Financial Officer 08 Mar 2023, 20:33
/report/000120919123010974-marshall-keith-w-2023-02-15 Prometheus Biosciences, Inc. 15 Feb 2023 3 -$578,400 4 Chief Financial Officer 17 Feb 2023, 20:34
/report/000120919123004138-marshall-keith-w-2023-01-17 Prometheus Biosciences, Inc. 17 Jan 2023 3 -$576,500 4 Chief Financial Officer 19 Jan 2023, 19:42
/report/000120919122062264-marshall-keith-w-2022-12-16 Prometheus Biosciences, Inc. 16 Dec 2022 1 $0 4 Chief Financial Officer 20 Dec 2022, 19:19
/report/000120919122061089-marshall-keith-w-2022-12-09 Prometheus Biosciences, Inc. 09 Dec 2022 2 $0 4 Chief Financial Officer 13 Dec 2022, 19:35
/report/000120919122031166-marshall-keith-w-2022-05-20 Prometheus Biosciences, Inc. 20 May 2022 1 $0 4 Chief Financial Officer 20 May 2022, 19:13
/report/000120919121064935-marshall-keith-w-2021-11-14 Prometheus Biosciences, Inc. 14 Nov 2021 1 $0 4 Chief Financial Officer 16 Nov 2021, 20:08